Polarization Sensitive Optical Coherence Tomography for Bronchoscopic Airway Smooth Muscle Detection in Bronchial Thermoplasty-Treated Patients With Asthma

Margherita Vaselli*, Pieta C. Wijsman, Joy Willemse, Annika W.M. Goorsenberg, Fabio Feroldi, Julia N.S. d'Hooghe, Jouke T. Annema, Johannes F. de Boer, Peter I. Bonta

*Corresponding author for this work

Research output: Contribution to JournalComment / Letter to the editorAcademic

Original languageEnglish
Pages (from-to)432-435
Number of pages4
JournalChest
Volume160
Issue number2
Early online date27 Mar 2021
DOIs
Publication statusPublished - Aug 2021

Funding

FUNDING/SUPPORT: The TASMA study is funded by the Dutch Lung Foundation [Grant 5.2.13.064JO ], the Netherlands Organization for Health Research and Development (ZonMw) [Grant 90713477 ], the Dutch Foundation ‘Asthma Bestrijding’ [Grant SAB 2018/041], and Boston Scientific. This work is part of the MedPhot research program 00770372 with project number 00770384, which is (partly) financed by the Dutch Research Council (NWO). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement [Grant 871124 ]. FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: J. T. A. reports grants from Boston Scientific , ZonMw , and the Dutch Lung Foundation , during the conduct of the study; and non-financial support from Boston Scientific. J. F. B. reports research grants from NWO (Dutch Science Foundation) and Heidelberg Engineering, during the conduct of the study; and royalties from intellectual property on core OCT technology owned and managed by his former employer, Massachusetts General Hospital Corp. P. I. B. reports grants from Boston Scientific, ZonMw, and the Dutch Lung Foundation, during the conduct of the study; and non-financial support from Boston Scientific, related to an investigator-initiated research grant. None declared (M. V., P. C. W., J. W., A. W. M. G., F. F., J. N. S. H.). FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: J. T. A. reports grants from Boston Scientific, ZonMw, and the Dutch Lung Foundation, during the conduct of the study; and non-financial support from Boston Scientific. J. F. B. reports research grants from NWO (Dutch Science Foundation) and Heidelberg Engineering, during the conduct of the study; and royalties from intellectual property on core OCT technology owned and managed by his former employer, Massachusetts General Hospital Corp. P. I. B. reports grants from Boston Scientific, ZonMw, and the Dutch Lung Foundation, during the conduct of the study; and non-financial support from Boston Scientific, related to an investigator-initiated research grant. None declared (M. V., P. C. W., J. W., A. W. M. G., F. F., J. N. S. H.).FUNDING/SUPPORT: The TASMA study is funded by the Dutch Lung Foundation [Grant 5.2.13.064JO], the Netherlands Organization for Health Research and Development (ZonMw) [Grant 90713477], the Dutch Foundation ‘Asthma Bestrijding’ [Grant SAB 2018/041], and Boston Scientific. This work is part of the MedPhot research program 00770372 with project number 00770384, which is (partly) financed by the Dutch Research Council (NWO). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement [Grant 871124].

FundersFunder number
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Lung Foundation Netherlands
Heidelberg Engineering
Horizon 2020
Massachusetts General Hospital5.2.13.064JO
Dutch Foundation ‘Asthma BestrijdingSAB 2018/041
Horizon 2020 Framework Programme871124
Boston Scientific Corporation00770384, 00770372
ZonMw90713477

    Cite this